Background: Aminoglycosides require highly accurate therapeutic drug monitoring owing to
their narrow therapeutic windows and toxic side effects. Therapeutic drug monitoring varies …

As leading hospitals, national and public university hospitals have a mission to treat a large
number of patients with intractable and/or critical diseases. Aminoglycosides broadly cover …

Background and objective: In 1989, a therapeutic drug monitoring service was established
in Assir Central Hospital, Abha, Saudi Arabia, by the Department of Clinical Pharmacology …

The aminoglycoside antibiotics gentamicin and tobramycin have been monitored
traditionally by measuring peak and trough drug levels in serum. We found interpretation of …

Objectives This monocentric, observational and retrospective survey was performed to
check the appropriateness between aminoglycoside prescriptions and inhibitor quotient to …

Although the measurement of aminoglycosides and glycopeptides in blood has been well
established, it has become evident that therapeutic drug monitoring (TDM) should be …

Objective: To compare the accuracy and precision of commercial assay techniques in the
measurement of gentamicin, tobramycin, amikacin, netilmicin and vancomycin in serum …

Background: Monitoring of the concentration of gentamicin in serum and plasma during
therapy is widely recommended and practiced in hospitals. Our aim was to develop a …

The aminoglycoside antibiotics are indispensible therapeutic agents; however, a high
incidence of toxic effects mandates that they be used with caution. Monitoring of serum …

Clinical laboratory investigations used to aid antimicrobial chemotherapy of serious infection
include routine sensitivity testing and, in the case of those drugs with a narrow therapeutic …